X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-01-12 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $37.50 | +300,000 | 11,584,280 | +3% | +$11,250,300 | ||||||
| D | 2022-01-03 | PRTA | Selkoe Dennis J. | Dir | S - Sale+OE | $47.45 | -5,000 | 4,208 | -54% | -$237,233 | |||||
| D | 2021-11-23 | PRTA | Walker Karin L | Chief Accounting Officer | S - Sale+OE | $57.88 | -4,519 | 0 | -100% | -$261,573 | |||||
| D | 2021-11-19 | PRTA | Malecek Michael J | See Remarks | S - Sale+OE | $55.00 | -10,000 | 0 | -100% | -$550,000 | |||||
| D | 2021-11-01 | PRTA | Karp Carol D. | Chief Regulatory Officer | S - Sale+OE | $57.18 | -10,000 | 0 | -100% | -$571,818 | |||||
| D | 2021-10-27 | PRTA | Malecek Michael J | See Remarks | S - Sale+OE | $58.53 | -10,000 | 0 | -100% | -$585,250 | |||||
| D | 2021-10-20 | PRTA | Walker Karin L | Chief Accounting Officer | S - Sale+OE | $60.25 | -23,000 | 0 | -100% | -$1,385,823 | |||||
| D | 2021-10-01 | PRTA | Selkoe Dennis J. | Dir | S - Sale+OE | $67.84 | -5,000 | 4,208 | -54% | -$339,176 | |||||
| D | 2021-10-01 | PRTA | Karp Carol D. | Chief Regulatory Officer | S - Sale+OE | $68.23 | -10,000 | 0 | -100% | -$682,336 | |||||
| D | 2021-09-09 | PRTA | Karp Carol D. | Chief Regulatory Officer | S - Sale+OE | $71.98 | -10,000 | 0 | -100% | -$719,847 | |||||
| D | 2021-07-30 | PRTA | Selkoe Dennis J. | Dir | S - Sale+OE | $49.47 | -5,000 | 4,208 | -54% | -$247,374 | |||||
| D | 2021-07-14 | PRTA | Henney Christopher S | Dir | S - Sale+OE | $55.46 | -11,108 | 0 | -100% | -$616,020 | |||||
| AD | 2021-07-12 | PRTA | Henney Christopher S | Dir | S - Sale+OE | $55.51 | -23,892 | 0 | -100% | -$1,326,128 | |||||
| D | 2021-07-12 | PRTA | Henney Christopher S | Dir | S - Sale+OE | $55.51 | -23,892 | 0 | -100% | -$1,326,128 | |||||
| D | 2021-06-25 | PRTA | Henney Christopher S | Dir | S - Sale+OE | $47.73 | -12,000 | 0 | -100% | -$572,819 | |||||
| D | 2021-06-22 | PRTA | Zago Wagner M. | Chief Scientific Officer | S - Sale+OE | $46.15 | -115,250 | 0 | -100% | -$5,318,769 | |||||
2021-03-24 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $20.75 | +875,000 | 11,034,280 | +9% | +$18,156,250 | ||||||
| M | 2021-02-23 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $21.24 | +55,200 | 10,159,280 | +1% | +$1,172,385 | |||||
| A | 2021-02-18 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $23.65 | +44,100 | 10,104,080 | 0% | +$1,043,075 | |||||
2021-02-18 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $3.68 | +44,100 | 10,104,080 | 0% | +$162,103 | ||||||
| D | 2021-02-18 | PRTA | Zago Wagner M. | Chief Scientific Officer | S - Sale+OE | $25.50 | -7,540 | 0 | -100% | -$192,270 | |||||
| DM | 2021-02-12 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $21.56 | +633,340 | 10,059,980 | +7% | +$13,657,270 | |||||
| D | 2021-02-12 | PRTA | Zago Wagner M. | Chief Scientific Officer | S - Sale+OE | $19.16 | -26,310 | 0 | -100% | -$504,057 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |